15
Lab. Meeting (1 st August) In Vitro studies to define the role of PERK in insulin synthesis * Using the 832/13 cell line

Lab. Meeting (1 st August)

Embed Size (px)

DESCRIPTION

Lab. Meeting (1 st August). In Vitro studies to define the role of PERK in insulin synthesis * Using the 832/13 cell line. Experimental Design. Equal numbers of 832/13 cells were plated on dishes These were starved for the sulphur containing amino acids - PowerPoint PPT Presentation

Citation preview

Page 1: Lab. Meeting (1 st  August)

Lab. Meeting (1st August)

In Vitro studies to define the role of PERK in insulin synthesis

* Using the 832/13 cell line

Page 2: Lab. Meeting (1 st  August)

Experimental Design

Equal numbers of 832/13 cells were plated on dishes

These were starved for the sulphur containing amino acids methionine and cysteine for half an hour

Methionine and cysteine labeled with S35 was added to this medium (should be incorporated in any new proteins synthesized)

The cell lysates were harvested at different time points (This would be indicative of radiolabeling of proteins in the intracellular

compartment)

Page 3: Lab. Meeting (1 st  August)

Determination of time point of maximum S35 incorporation

Comparison of beta emission generated signal from

- Total cell lysates- (TCA precipitated) Total protein (from the cell

lysates)

: Gives data regarding percentage incorporation

Page 4: Lab. Meeting (1 st  August)

Determination of time point of maximum S35 incorporation

S35 Incorporation: Total Protein

0

5

10

15

20

25

30

35

Time

Perc

enat

ge

Inco

rpor

atio

n

Series1

Page 5: Lab. Meeting (1 st  August)

Studying protein synthesis (intracellular compartment) using S35 labeling

832/13 cells

832/13 cells with lacZ

832/13 cells with ▲C

INCUBATED for 36 hours, no significant cell death

at the time of harvesting

= Untreated controls

= (adenovirus vector without the dominant negative construct)

=(adenovirus vector with the dominant negative construct)

Page 6: Lab. Meeting (1 st  August)

S35 incorporation following 30 mins of pulsing

0

5

1015

20

25

3035

40

45

% incrprn.

s35 incrprn final & revised

Untreated lacZ ▲C

Page 7: Lab. Meeting (1 st  August)

Labeling as a fraction of total Protein content in samples

Untreated LacZ ▲C

total protein

labeled fraction

total protein

labeled fraction

total protein

labeled fraction

0

500

1000

1500

2000

2500

comparison total protein vs labeled protein

total protein

labeled fraction

Page 8: Lab. Meeting (1 st  August)

Autoradiograph for a western of total protein (TCA precipitated samples) to check for signal

Page 9: Lab. Meeting (1 st  August)

Immunoprecipitation for insulin

IP

Total protein

IP

Total protein

IP

Total protein

02000000400000060000008000000

10000000120000001400000016000000

CPM

IPed protein as a fraction of total labeled protein

IP

Total protein

Untreated LacZ ▲C

Scintillation counter readings

Page 10: Lab. Meeting (1 st  August)

Immunoprecipitation for insulin

Iped protein(Ins)

0.62

0.63

0.64

0.65

0.66

0.67

0.68

Percent

Iped Insulin as a percentage

Iped protein(Ins)

Untreated LacZ ▲C

Page 11: Lab. Meeting (1 st  August)

Immunoprecipitation for insulin Non Reducing gel (without Urea)

Non Specific Aggregates?

Untreated LacZ ▲C

Page 12: Lab. Meeting (1 st  August)

Immunoprecipitation for insulin Reducing gel (with Urea)

Page 13: Lab. Meeting (1 st  August)

Immunoprecipitation for insulin

ImageQuant

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

Avera

ge s

ign

al/

are

a

ImageQuant

Suggests higher insulin synthesis in delta C treated cells

Untreated LacZ ▲C

Page 14: Lab. Meeting (1 st  August)

Insulin Content

Daorongs data suggests that

- 1. Insulin content in delta C treated cells is lower

2. Delta C treated cells secrete lower amounts of insulin when stimulated with secretagogues

• My data suggests that 1. Global protein synthesis is reduced

2. Insulin synthesis is increased

Page 15: Lab. Meeting (1 st  August)

Next Step

More replicates

Check insulin content, too for untreated and vector treated controls for insulin content under similar conditions

IP another abundant protein